Advanced search
Publication Cover
Renal Failure Volume 25, 2003 - Issue 4
Submit an article Journal homepage
301
Views
1
CrossRef citations to date
0
Altmetric
CLINICAL STUDY

Urinary Transforming Growth Factor-β1 Excretion in Renal Allograft Recipients During the Early Post-transplantation Period

Dr. Dimitrios S. Goumenos Department of Internal Medicine-Nephrology, University Hospital, Patras, GreeceCorrespondence[email protected]
,
Sotiris Tsakas Department of Internal Medicine-Nephrology, University Hospital, Patras, Greece
,
Dionisios Karavias Department of Surgery, University Hospital, Patras, Greece
,
Irini Savidaki Department of Internal Medicine-Nephrology, University Hospital, Patras, Greece
,
Thoedoros Karatzas Department of Surgery, University Hospital, Patras, Greece
&
John G. Vlachojannis Department of Internal Medicine-Nephrology, University Hospital, Patras, Greece
Pages 561-568 | Published online: 07 Jul 2009

References

  • Roberts A.B., Sporn M.B. Physiological action and clinical applications of transforming growth factor-β. Growth Factors 1993; 8(1)1–9
  • Border W.A., Noble N.A. Transforming growth factor-β in tissue fibrosis. N. Engl. J. Med. 1994; 331(19)1286–1291
  • Lawrence A.D. Transforming growth factor-β: an overview. Kidney Int. 1995; 47(suppl. 49)S19–S23
  • Yamamoto T., Noble N.A., Miller D.A., Border W.A. Sustained expression of TGF-β underlies development of progressive kidney fibrosis. Kidney Int. 1994; 45(3)916–927
  • Yamamoto T., Noble N.A., Cohen A.H., Nast C.C., Hishiba A., Gold L.I., Border W.A. Expression of TGF-β in human glomerular disease. Kidney Int. 1996; 49(2)461–469
  • Goumenos D.S., Tsamandas A.C., Oldroyd S., Sotsiou F., Tsakas S., Petropoulou C., Bonikos D., El Nahas A.M., Vlachojannis J.G. Transforming growth factor-β1 and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease. Nephron 2001; 87(3)240–248
  • Campistol J.M., Iñigo P., Larios S., Bescos M., Oppenheimer F. Role of transforming growth factor-β1 in the progression of chronic allograft nephropathy. Nephrol. Dial. Transpl. 2001; 16(Suppl 1)S114–S116
  • Grandaliano G., Di Paolo S., Monno R., Stallone G., Ranieri E., Pontrelli P., Gesualdo L., Schena F.P. Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy. Transplantation 2001; 72(8)1437–1443
  • Shihab F.S., Tanner A.M., Shao Y., Weffer M.I. Expression of TGF-β1 and matrix proteins is elevated in rats with chronic rejection. Kidney Int. 1996; 50(6)1904–1913
  • Horvath L.Z., Friess H., Schilling M., Borisch B., Deflorin J., Gold L., Korc M., Büchler M.W. Altered expression of transforming growth factor-βs in chronic renal rejection. Kidney Int. 1996; 50(2)489–498
  • Pankewycz O.G., Miao L., Isaacs R., Guan J., Pruett T., Haussman G., Sturgill B.C. Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity. Kidney Int. 1996; 50(5)1634–1640
  • Honkanen E., Teppo A.M., Tornroth T., Groop P.H., Groonhagen-Riska C. Urinary transforming growth factor-β1 in membranous glomerulonephritis. Nephrol. Dial. Transplant. 1997; 12(12)2562–2568
  • Khanna A., Kapur S., Sharma V., Li B., Suthanthiran M. In vivo hyperexpression of transforming growth factor-β1 in mice: stimulation by cyclosporine. Transplantation 1997; 63(7)1037–1039
  • Amend W.J.C., Vincenti F., Tomlanovich S.J. The first two post-transplantation months. Handbook of Kidney Transplantation, 3rd Ed., G.M. Danovitch. Lippincott, Williams and Wilkins, Philadelphia 2001; 163–181
  • Shoskes D.A., Halloran P.F. Delayed graft function in renal transplantation: etiology, management, and long-term significance. J. Urol. 1996; 155(6)1831–1840
  • Smith S.D., Wheeler M.A., Lorber M.I., Weiss R.M. Temporal changes of cytokines and nitric oxide products in urine from renal transplant patients. Kidney Int. 2000; 58(2)829–837
  • Mohamed M.A.S., Robertson H., Booth T.A., Balupuri S., Kirby J.A., Talbot D. TGF-β expression in renal transplant biopsies. Transplantation 2000; 69(5)1002–1005
  • Massy Z.A., Guijarro C., Wiederkehr M.R., Ma J.Z., Kasiske B.L. Chronic renal allograft rejection: immunologic and nonimmunologic risk factors. Kidney Int. 1996; 49(2)518–524

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.